GSTM1 and non-small cell lung carcinoma: I. Gauthier et al. [39] explored the relationship between hemoglobin levels and the outcomes of adjuvant chemotherapy in resected non-small-cell lung cancer and found that lower Hb (<120 g/L) was predicted for in-hospital stay and worse poor quality of life.